- In June 2024, GE Healthcare enhanced its nuclear imaging devices market presence with the MINItrace Magni, a compact cyclotron for in-house production of PET tracers and radiometals. In addition, the Omni Legend 21 cm PET/CT system addresses growing healthcare demands, while Clarify DL, a deep learning technology, promises clearer and more accurate imaging, improving diagnostic efficiency
- In February 2024, GE Healthcare partnered with MedQuest Associates to optimize multi-site outpatient imaging networks. This collaboration combines GE’s advanced technologies with MedQuest’s infrastructure, expanding access to high-quality nuclear imaging and enhancing patient care
- In May 2023, Philips, Elekta, and Mercurius Health entered a 3-year agreement to install diagnostic and therapeutic oncology equipment at Robert Janker Klinik in Germany. This partnership strengthens the market for advanced oncology-focused nuclear imaging solutions in Europe
- In November 2022, Canon, Inc. established Canon Healthcare USA, Inc., enhancing its position in the U.S. medical market. This move aims to expand Canon's market share in nuclear imaging devices by better serving the region's growing healthcare needs
- In June 2022, Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system, receiving CE and FDA approval. Its advanced capabilities, including low-dose CT with up to 64 slices, improve diagnostic accuracy, promoting the adoption of hybrid imaging solutions in clinical settings
